HomeDealsNegotiationsPolicyPipelineMoneyPeopleDataThe WeekPharmTech 100Deal TrackerResearch

Drugs, Discounts and Data: Crafting Sustainability in an Imperfect System

Today's guest post comes from Angie Franks, Chief Executive Officer at Kalderos. As Angie explains, the industry still lacks the transparency needed to effectively manage where discounts occur and how funds move across stakeholders. She argues that improving visibility and coordination across the ec

By Drug Channels · May 29, 2026 · via Drug Channels

This is an aggregated industry headline. Read the full story at Drug Channels

Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
MannKind seeks long-awaited sales boost with inhaled insulin approval for kids
The WeekFiercePharma ↗
With a pediatric approval in hand for Afrezza, MannKind may finally have the boost it needs to make an impact …
May 30, 2026
Legend scientific founder returns to ASCO with new ambition for high-yield, non-gene-editing CAR-T platform
The WeekFierceBiotech ↗
Nine years after wowing the audience at the American Society of Clinical Oncology annual meeting with a CAR-T …
May 30, 2026
Leadership Change, Clinical Setbacks, and an ADC Milestone in a Busy FDA Week
The WeekBriefing
Allogene’s founding CEO steps down, Agios halts development of tebapivat, AbbVie gains approval for Decnupaz, …
May 30, 2026